Stock GILD34 GILEAD SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Gilead Sciences, Inc. Sao Paulo

Equities

GILD34

BRGILDBDR000

Market Closed - Sao Paulo
Other stock markets
 18:51:12 10/05/2024 BST 		5-day change 1st Jan Change
169.9 BRL -1.92% Intraday chart for Gilead Sciences, Inc. +3.77% -11.73%
05-07 Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates MT
05-02 UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating MT

Chart calendar Gilead Sciences, Inc.

72726776ac8c5f502def454cccbe.u9UMA0ye8b4F4UTuMp-wdpIDwQ2036xHoTJKsJHdjAY.7Z5Gc33IuoxXpwCCa-3GH6tWsUrjuO8SzQV9gteR_Wv8vEd5Afqg5jyNDQ~ce5ebf0f90c1782a979d0ad5b6082585

Upcoming events on Gilead Sciences, Inc.

14/05/2024 19:20 BofA Securities Health Care Conference
15/05/2024 15:30 RBC Capital Markets Global Healthcare Conference
23/05/2024 22:00 American Society of Clinical Oncology Meeting - Abstract No: #e16500
31/05/2024 20:45 American Society of Clinical Oncology Annual Meeting - Abstract No: #LBA8500
01/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract No: #3029
01/06/2024 18:30 American Society of Clinical Oncology Annual Meeting - Abstract No: #433248
01/06/2024 19:30 American Society of Clinical Oncology Annual Meeting - Abstract No: #TPS4195
01/06/2024 21:00 American Society of Clinical Oncology Annual Meeting - Abstract No: #LBA1004
02/06/2024 14:00 American Society of Clinical Oncology Annual Meeting - Abstract No: #3508
02/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract No: #TPS4618
02/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract No: #TPS6130
02/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract No: #TPS4627
02/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract No: #TPS1140
02/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract No: #1102
02/06/2024 15:00 American Society of Clinical Oncology Annual Meeting - Abstract No: #1075

Past events on Gilead Sciences, Inc.

08/05/2024 18:00 Annual General Meeting
25/04/2024 21:30 Q1 2024 Earnings Call
25/04/2024 21:02 Q1 2024 Earnings Release
14/03/2024 14:00 Investor Meeting
13/03/2024 Ex-dividend day
13/03/2024 15:15 Barclays Global Healthcare Conference
12/03/2024 14:00 Leerink Partners Global Biopharma Conference
05/03/2024 17:50 TD Cowen Health Care Conference
02/03/2024 Conference on Retroviruses and Opportunistic Infections
06/02/2024 22:00 Q4 2023 Earnings Call
06/02/2024 21:02 Q4 2023 Earnings Release
08/01/2024 18:30 JPMorgan Healthcare Conference
13/12/2023 Ex-dividend day
12/12/2023 02:00 American Society of Hematology Meeting - Abstract Number : 4884
12/12/2023 02:00 American Society of Hematology Meeting - Abstract Number : 5101
12/12/2023 02:00 American Society of Hematology Meeting - Abstract Number : 4869
12/12/2023 02:00 American Society of Hematology Meeting - Abstract Number : 4865
12/12/2023 02:00 American Society of Hematology Meeting - Abstract Number : 5100
12/12/2023 02:00 American Society of Hematology Meeting - Abstract Number : 4864
12/12/2023 02:00 American Society of Hematology Meeting - Abstract Number : 5082

Past dividends on Gilead Sciences, Inc.

13/03/2024 Quarterly 0.77 USD
13/12/2023 Quarterly 0.75 USD
13/09/2023 Quarterly 0.75 USD
13/06/2023 Quarterly 0.75 USD
13/03/2023 Quarterly 0.75 USD
13/12/2022 Quarterly 0.73 USD
13/09/2022 Quarterly 0.73 USD
13/06/2022 Quarterly 0.73 USD
13/03/2022 Quarterly 0.73 USD
13/12/2021 Quarterly 0.71 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		22 449
22 305
0.65%		24 689
24 482
0.84%		27 305
26 657
2.43%		27 281
26 518
2.88%		27 116
27 083
0.12%
27 598

EBITDA
Million USD		Released
Forecast
Spread 		12 468
13 029
-4.3%		13 184
13 142
0.32%		14 598
15 539
-6.05%		14 283
13 783
3.63%		13 177
13 123
0.41%
9 607

EBIT
Million USD		Released
Forecast
Spread 		11 064
11 571
-4.38%		11 704
11 599
0.9%		12 548
13 943
-10.01%		12 180
12 141
0.32%		10 484
10 687
-1.9%
7 345

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		5 160
5 333
-3.24%		1 669
1 636
2.01%		8 278
9 507
-12.92%		5 814
5 658
2.76%		6 859
7 323
-6.33%
1 552

Net income
Million USD		Released
Forecast
Spread 		5 386
4 292
25.5%		123
137
-10.03%		6 225
7 205
-13.6%		4 592
4 383
4.77%		5 665
5 872
-3.52%
403

EPS
USD		Released
Forecast
Spread 		4,22
3,43
23.14%		0,10
0,12
-16.23%		4,93
5,75
-14.19%		3,64
3,48
4.75%		4,50
4,69
-3.96%
0,35

Announcement Date04/02/2004/02/2101/02/2202/02/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		7 244
6 615
9.51%		6 590
6 279
4.96%		6 260
5 873
6.6%		7 042
6 133
14.82%		7 389
6 630
11.45%		6 352
6 326
0.41%		6 599
6 454
2.24%		7 051
6 800
3.69%		7 115
7 104
0.16%		6 686
6 349
5.31%
6 718


6 979


7 238


6 484

EBITDA
Million USD		Released
Forecast
Spread 		2 042
3 449
-40.79%		4 049
3 438
17.79%		3 195
3 183
0.38%		3 811
3 049
24.99%		3 227
2 865
12.63%		2 883
3 407
-15.38%		3 258
3 343
-2.54%		3 908
3 636
7.49%		3 427
3 495
-1.94%
-889


3 365


3 541


3 543




EBIT
Million USD		Released
Forecast
Spread 		1 507
2 905
-48.13%		3 524
3 060
15.15%		2 670
2 602
2.6%		3 286
2 529
29.91%		2 699
2 622
2.92%		2 243
2 658
-15.62%		2 277
2 776
-17.99%		3 224
3 060
5.37%		2 739
2 940
-6.84%		-1 117
-1 679
33.48%
2 688


2 890


2 911


2 605

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		759
1 966
-61.4%		-152
2 158
-107.05%		1 503
1 664
-9.68%		2 432
1 674
45.28%		2 031
1 840
10.37%		1 300
1 900
-31.59%		1 588
1 969
-19.35%		2 318
2 275
1.91%		1 653
2 090
-20.89%		-4 486



1 802


2 126


2 248


2 197

Net income
Million USD		Released
Forecast
Spread 		382
1 424
-73.17%		19,0
1 611
-98.82%		1 144
1 367
-16.32%		1 789
1 248
43.39%		1 640
1 438
14.02%		1 010
1 587
-36.37%		1 045
1 545
-32.38%		2 180
1 801
21.07%		1 429
1 599
-10.66%		-4 170
-2 888
-44.38%
1 365


1 596


1 651


1 651

EPS
USD		Released
Forecast
Spread 		0,30
1,14
-73.64%		0,02
1,34
-98.5%		0,91
1,11
-17.89%		1,42
1,01
40.93%		1,30
1,15
13%		0,80
1,23
-34.75%		0,83
1,20
-30.93%		1,73
1,43
20.88%		1,14
1,28
-11.05%		-3,34
-1,92
-74.06%
1,10


1,27


1,31


1,24

Announcement Date01/02/2228/04/2202/08/2227/10/2202/02/2327/04/2303/08/2307/11/2306/02/2425/04/24----

Upcoming sector events for Gilead Sciences, Inc.

12/05/2024 PHARMANUTRA S.P.A.: Q1 2024 Earnings Release
12/05/2024 AARTI PHARMALABS LIMITED: Q4 2024 Earnings Release
12/05/2024 SHIONOGI & CO., LTD.: Q4 2023 Earnings Release
12/05/2024 MOCHIDA PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
12/05/2024 SAWAI GROUP HOLDINGS CO., LTD.: Q4 2023 Earnings Release
12/05/2024 MEGA LIFESCIENCES: Q1 2024 Earnings Release
12/05/2024 ALMIRALL, S.A.: Q1 2024 Earnings Release
12/05/2024 JW PHARMACEUTICAL CORPORATION: Q1 2024 Earnings Release (Projected)
12/05/2024 DONGKOOK PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
12/05/2024 GREEN CROSS HOLDINGS CORPORATION: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Gilead Sciences, Inc.

Today 11:50 ANI PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
Today PIRAMAL PHARMA LIMITED: Q4 2024 Earnings Release
Today NEULAND LABORATORIES LIMITED: Q4 2024 Earnings Release
Today NIPPON SHINYAKU CO., LTD.: Q4 2023 Earnings Release
Today ROHTO PHARMACEUTICAL CO.,LTD.: Q4 2023 Earnings Release (Projected)
Today KYORIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
Today JCR PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
Today TTY BIOPHARM COMPANY LIMITED: Q1 2024 Earnings Release (Projected)
09/05/2024 14:58 SCINOPHARM TAIWAN, LTD.: April 2024 Sales and Revenue Release
09/05/2024 14:06 ABBOTT INDIA LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GILD Stock
  4. GILD34 Stock
  5. Calendar Gilead Sciences, Inc.